U.S. Capital Markets Stock News

In June 2026, J&J Snack Foods Corp. was moved out of several Russell growth benchmarks and added to multiple Russell value-oriented indices, including the Russell 2000 Value, Russell 2500 Value, and Russell 3000 Value benchmarks. This shift from growth to value classifications changes how index funds and style-focused investors may view J&J Snack Foods within their portfolios. Next, we’ll examine how J&J Snack Foods’ reclassification into value-focused Russell indices could influence its...

Shopify’s valuation picture has become more finely balanced, with the stock up 94.1% over the past three years, while the Discounted Cash Flow (DCF) intrinsic value estimate now lines up close to the current share price and earnings multiples screen as expensive. Shopify’s 94.1% three year return signals that a large part of the story is already reflected in the share price, so fresh upside may need stronger fundamentals to support it. Expectations around continued revenue growth supported...

Index additions and dividend decision put Millrose Properties in focus Millrose Properties (MRP) has drawn fresh attention after being added to the Russell 1000 Defensive Index and Russell 1000 Value-Defensive Index, alongside a recently declared quarterly cash dividend. See our latest analysis for Millrose Properties. The recent dividend declaration and index inclusions have come as Millrose Properties’ share price has eased in the short term, with the 7 day share price return down 7.53% and...

Amer Sports, Inc. (NYSE:AS) was recently added to multiple Russell growth indices, including the Russell Midcap Growth, Russell 1000 Growth, Russell 2500 Growth, Russell Small Cap Comp Growth, Russell 3000E Growth, and Russell 3000 Growth benchmarks. This broad inclusion across the Russell growth family could increase index-linked ownership and visibility for Amer Sports among growth-focused institutional investors. Now we’ll explore how Amer Sports’ broad inclusion in Russell growth indices...

La-Z-Boy stock has delivered a 43.7% return over the past three years, yet current valuation work suggests the shares may still trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach. Over the last three years, La-Z-Boy has returned 43.7%, which puts recent share performance firmly in positive territory but not at levels that clearly rule out further upside if the valuation case holds. For La-Z-Boy, the ability to keep converting earnings into steady cash flow...

In late June 2026, Recursion Pharmaceuticals, Inc. was added to several Russell value and small-cap benchmarks, widening its footprint across key US equity indices and increasing its visibility to institutional and index-tracking investors. This broader index inclusion, combined with growing attention on its AI-native drug discovery platform and advancing clinical pipeline, is subtly reshaping how the market weighs Recursion’s mix of high innovation, high costs, and partnership-driven...

Hamilton Lane stock has had a tough year, with a steep decline in the share price set against valuation checks that now lean toward the shares looking cheap on several measures. With the company still active in raising and deploying capital, investors are weighing whether the current level reflects a reset in expectations or a potential mispricing. Over the past 12 months, Hamilton Lane shares have fallen 42.4%, which naturally raises the question of whether sentiment has moved further than...

Tariffs back in the headlines can rattle import heavy retailers, but they can also shine a light on companies that look better prepared for higher trade frictions. With potential 10% to 12.5% duties on goods from 60 countries and renewed global tariffs on the table, some large U.S. consumer retailers with strong North American focus and healthier balance sheets may be positioned to handle higher costs more effectively than peers. This article walks through 3 stocks from a U.S. Import...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In such an environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on future growth prospects.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings projected to grow by 18% annually in the coming years. In this environment, identifying growth companies with strong insider ownership can be a strategic approach as it often indicates confidence from those closest to the business and potential alignment with shareholder interests.

In the last week, the United States market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. Investing in penny stocks—though often considered a niche area—can still present growth opportunities, especially when these stocks are supported by strong financial health. Here, we explore several intriguing penny stocks that stand out for their financial strength and potential for long-term growth.

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals (NasdaqGS:CRNX) in an all cash deal valued at about US$10b. The boards of both companies approved the transaction unanimously. The deal is expected to close in Q3 2026, subject to regulatory and Crinetics shareholder approvals. Crinetics Pharmaceuticals focuses on endocrine diseases, an area where larger drug makers have been looking to expand their presence. Vertex is set to add Crinetics' pipeline and clinical expertise to...

In late June 2026, Core & Main, Inc. (NYSE:CNM) was removed from multiple Russell growth benchmarks, including the Russell 1000 Growth, 3000E Growth, 2500 Growth, Midcap Growth, and Small Cap Comp Growth indices. This broad index removal could reshape the company’s investor base and trading patterns as funds tracking these benchmarks adjust their Core & Main holdings. We’ll now explore how Core & Main’s removal from several Russell growth indices may affect its previously outlined investment...

MillerKnoll, Inc. recently reported past fourth-quarter and full-year 2026 results showing higher sales of US$1,004.2 million and US$3.84 billion respectively, alongside a move from losses to net income and positive earnings per share from continuing operations. The company also issued fiscal 2027 guidance calling for US$928 million–US$968 million in first-quarter sales and US$3.93 billion–US$4.13 billion for the full year, signaling expectations for higher revenue with gross margins...

In late June 2026, BioLife Solutions, Inc. (NasdaqCM: BLFS) was added to multiple Russell value-oriented benchmarks, including the Russell 2000 Value, 2500 Value, 3000 Value, 3000E Value, Microcap Value, and Small Cap Comp Value indices. This broad index inclusion enhances BioLife Solutions’ visibility with institutional investors and index-tracking funds, potentially affecting liquidity, ownership mix, and how the market assesses its role within the cell and gene therapy ecosystem. Next,...

Regional bank stocks are back in focus as the Federal Reserve signals caution on future rate hikes, inflation stays sticky, and economic data sends mixed messages. For investors watching how changing interest rate expectations, loan demand, and net interest margins might affect U.S. financials, this uncertainty can look like both risk and opportunity. This article breaks down how the latest Fed tone and employment trends connect to U.S. Regional Bank Stocks, and highlights 3 stocks from our...

On 27 June 2026, Paymentus Holdings, Inc. (NYSE: PAY) was added to a wide range of Russell indexes, including the Russell 2000, 2500, 3000, and multiple growth and defensive benchmarks, expanding its presence across key small- and broad-cap US equity indices. This broad-based index inclusion increases Paymentus' visibility with institutional investors and index-tracking funds, potentially influencing trading volumes, ownership base, and how the market evaluates its role in digital bill...

With grocery and gas bills squeezing household budgets, consumer staples stocks are sitting at the center of a crucial affordability story. High inflation at 4.2%, wage pressure, and weakening confidence from 57% of Americans who see the economy as worsening are reshaping how and where people spend. That creates different types of risks and potential opportunities across food, beverage, and household product companies. This article walks through 3 stocks from our Consumer Staples screener...

When a major lender like HSBC pulls back from riskier private credit, it sends a clear signal about how banks are thinking about risk, capital and funding costs. For you as an investor, that shift can affect where the steadier opportunities and pressure points show up across large, established financial stocks. This article looks at how tightening underwriting standards and rising regulatory attention around private credit might filter through to more conservative banking stocks. It will walk...

Progyny, Inc. was recently removed from the Russell 2000 Dynamic Index, an index change that typically prompts rebalancing by index-tracking investors. This index removal matters because forced portfolio adjustments can alter trading volumes and liquidity, potentially affecting how Progyny’s underlying business story is perceived. We’ll now examine how Progyny’s removal from the Russell 2000 Dynamic Index may influence its existing investment narrative and risk profile. Invest in the nuclear...

In late June 2026, Travere Therapeutics, Inc. was removed from several major Russell value and small-cap benchmarks, including the Russell 2000 Value, Russell 3000 Value, Russell 2500 Value, Russell Small Cap Comp Value, and Russell 3000E Value indices. This broad index removal can prompt forced portfolio rebalancing by index-tracking funds, potentially shifting how institutional investors assess Travere’s role in diversified healthcare portfolios. We’ll now examine how Travere’s removal...

Churchill Capital Corp XI (CCXI) drew fresh attention after outlining a new unsecured promissory note of up to US$1,500,000, convertible into units at US$10.00. This adds another layer to its pending Agility Robotics merger. See our latest analysis for Churchill Capital Corp XI. The Agility Robotics deal and the new convertible note come on the heels of a sharp shift in market sentiment, with Churchill Capital Corp XI’s 30 day share price return of 67.35% and year to date share price return...

The latest ISM Services Index reading points to a US services sector that is still expanding, but with signs of cooling demand and shifting cost pressures. For investors, that mix of steady growth, moderating activity, and cooler input costs can change how certain service stocks look on a risk and reward basis. This article unpacks what that backdrop might mean for companies in our US Services Sector Stocks screener and highlights 3 stocks that appear positively exposed to these conditions,...

Cooling Dutch inflation, with June consumer prices up 2.9% year on year and the HICP reading at 2.5%, is putting fresh attention on interest rate expectations and on sectors that tend to react when borrowing costs move. If the European Central Bank leans more dovish, funding conditions and asset valuations across Financials and Real Estate could shift in ways that matter for your portfolio. This article highlights 3 large, financially solid stocks from our Interest Rate Sensitive Sectors...